Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "negative symptoms"

Clinical trialUNITERAREMay 1

New Recruiting Trial: Multi-target TMS for Schizophrenia Negative Symptoms

Researchers are testing a new brain stimulation treatment called multi-target TMS to help people with schizophrenia who experience negative symptoms — like difficulty feeling emotions, motivation, or social connection. This treatment uses magnetic pulses to stimulate specific areas of the brain. The study is now accepting patients and will take place at Shanghai Mental Health Center starting in May 2026.

WHY IT MATTERSThis trial offers a potential new treatment option for schizophrenia negative symptoms, which are often difficult to treat with current medications and significantly impact quality of life and functioning.
You can act on thisschizophrenia

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases